A highly efficient signal-transduction strategy utilizing Fe-coordinated DNA nanospheres (FDNSs)─a programmable, metal-nucleic acid assembly─as a high-capacity DNA reservoir for amplified biomarker sensing, providing a robust and portable solution for cancer screening in resource-limited settings.
Abstract
The development of ultrasensitive protein detection platforms is pivotal for early cancer diagnosis, yet existing methods are often constrained by inefficient "protein-to-signal" conversion and complex instrumentation. While CRISPR-Cas-based biosensors offer higher sensitivity for nucleic acids, their application in protein analysis is fundamentally limited by the low nucleic acid loading capacity and tedious functionalization of traditional inorganic signal carriers such as gold nanoparticles and metal-organic frameworks (MOFs). Herein, we report a highly efficient signal-transduction strategy utilizing Fe-coordinated DNA nanospheres (FDNSs)─a programmable, metal-nucleic acid assembly─as a high-capacity DNA reservoir for amplified biomarker sensing. Unlike conventional surface-modified inorganic nanoparticles, the solid-core FDNSs achieve an unprecedented DNA loading density and exhibit specific stimulus-responsive degradation. In this FACC (FDNS-activated CRISPR chip) platform, the recognition of tumor biomarkers triggers the rapid collapse of FDNSs, releasing a massive flux of barcode DNA that subsequently activates the CRISPR-Cas12a system within a microfluidic device. This dual-amplification architecture enables the ultrasensitive quantification of prostate-specific antigen (PSA) and carcinoembryonic antigen (CEA) with detection limits of 0.028 fg/mL and 0.0265 fg/mL, respectively. By replacing complex inorganic carriers with this programmable DNA assembly, our platform simplifies the sensing workflow and significantly enhances sensitivity, providing a robust and portable solution for cancer screening in resource-limited settings.
A modular fluorescence signal transduction platform integrating aptamer-functionalized magnetic beads, lanthanide metal-organic frameworks, and CRISPR-Cas12a-mediated collateral cleavage amplification for sensitive cTnI detection, providing a universal strategy to expand CRISPR-Cas systems toward non-nucleic acid targe...
Yongzhen Liu, Long Yu, Yongjin Shen et al.· Analytical Chemistry· 0 citations
The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (Cas) system enables sensitive and specific biomolecular detection due to its programmability, high fidelity, and signal amplification. Herein, a novel universal CRISPR/Cas12a-G4 DNAzyme-TMB (Cas-GT) enzymatic biosensi...
Huisi Qin, Jing-Xuan Liu, Yang Luo et al.· In Analysis· 0 citations
Programmable nucleases have obtained widespread application in the field of pathogen detection, yet they face considerable challenges in multiplex detection. As a sister technology to CRISPR/Cas systems, Argonaute proteins (Ago) possess programmability, sequence specificity, and multi-turnover capability, rendering t...
A novel biosensing platform designed for the ultrasensitive detection of dengue viral RNA, which demonstrates excellent specificity, showing no cross-reactivity with Zika, Japanese encephalitis, or West Nile viruses, and also exhibits good reproducibility.
An RCA-CRISPR-SERS cascade amplification platform that provides a highly sensitive and specific method for detecting miR-21 in exosomes, offering potential clinical value for the early diagnosis and dynamic monitoring of colorectal cancer.
Jian Tao, Bin-Bin Zeng, Cai-Li Bi et al.· International Journal of Nan...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.